Dianthus Therapeutics, Inc. /DE/ SEC filings DNTH
Dianthus Therapeutics, Inc. /DE/ has 658 filings in SEC EDGAR's recent list, going back to Nov 23, 2016. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| S-3ASR | Automatic shelf registration | Sep 18, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Jun 12, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2026 | May 21, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 9, 2026 | — |
| DEF 14A | Proxy statement | Apr 9, 2026 | May 21, 2026 |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Material agreement
|
Mar 12, 2026 | Mar 10, 2026 |
| 424B5 | Prospectus supplement | Mar 11, 2026 | — |
| S-3MEF | Filing | Mar 10, 2026 | — |
| 424B5 | Prospectus supplement | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| EFFECT | Filing | Jan 30, 2026 | — |
| CORRESP | Letter to the SEC | Jan 29, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2026 | — |
| S-3 | Shelf registration | Jan 28, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Oct 16, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 11, 2025 | Sep 9, 2025 |
| 424B5 | Prospectus supplement | Sep 11, 2025 | — |
| 424B5 | Prospectus supplement | Sep 8, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2025 | Sep 8, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 22, 2025 | May 22, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 10, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 22, 2025 |
| S-8 | Employee stock plan registration | Mar 11, 2025 | — |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Other events
|
Dec 12, 2024 | Dec 12, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| RW | Filing | Oct 21, 2024 | — |
| 424B5 | Prospectus supplement | Oct 11, 2024 | — |
| 424B3 | Prospectus | Oct 11, 2024 | — |
| EFFECT | Filing | Oct 9, 2024 | — |
| EFFECT | Filing | Oct 9, 2024 | — |
| CORRESP | Letter to the SEC | Oct 7, 2024 | — |
| CORRESP | Letter to the SEC | Oct 7, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 7, 2024 | — |
| S-3 | Shelf registration | Oct 1, 2024 | — |
| S-3 | Shelf registration | Oct 1, 2024 | — |
| 424B3 | Prospectus | Sep 16, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2024 | Sep 16, 2024 |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 6, 2024 | Jun 6, 2024 |
| 424B3 | Prospectus | May 28, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2024 | May 23, 2024 |
| 424B3 | Prospectus | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 11, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEF 14A | Proxy statement | Apr 11, 2024 | May 23, 2024 |
| EFFECT | Filing | Mar 27, 2024 | — |
| CORRESP | Letter to the SEC | Mar 25, 2024 | — |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| S-1/A | Amended registration statement | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| CORRESP | Letter to the SEC | Feb 7, 2024 | — |
| S-1/A | Amended registration statement | Feb 7, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| UPLOAD | Letter from the SEC | Dec 28, 2023 | — |
| S-1/A | Amended registration statement | Dec 21, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 21, 2023 | Dec 21, 2023 |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 25, 2023 | Oct 19, 2023 |
| S-8 | Employee stock plan registration | Oct 4, 2023 | — |
| S-3 | Shelf registration | Oct 4, 2023 | — |
| 8-K/A |
Amended current report
Results of operations, Officer or director change, Other events
|
Sep 21, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Sep 12, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Sep 8, 2023 | Sep 8, 2023 |
| 425 | Filing | Aug 31, 2023 | — |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Aug 1, 2023 | — |
| 424B3 | Prospectus | Aug 1, 2023 | — |
| CORRESP | Letter to the SEC | Jul 31, 2023 | — |
| S-4/A | Filing | Jul 31, 2023 | — |
| CORRESP | Letter to the SEC | Jul 17, 2023 | — |
| S-4/A | Filing | Jul 17, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2023 | — |
| CORRESP | Letter to the SEC | Jun 22, 2023 | — |
| S-4/A | Filing | Jun 22, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2023 | — |
| 425 | Filing | May 19, 2023 | — |
| 8-K |
Current report
Officer or director change
|
May 19, 2023 | May 15, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| S-4 | Registration for a merger or exchange | May 15, 2023 | — |
| 8-A12B | Filing | May 3, 2023 | — |
| 425 | Filing | May 3, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Regulation FD disclosure
|
May 3, 2023 | May 2, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Apr 6, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-A12B | Filing | Mar 31, 2023 | — |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Feb 7, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Feb 2, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 25, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 20, 2022 | Dec 20, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Dec 13, 2022 | Dec 9, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 424B5 | Prospectus supplement | Aug 18, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Aug 17, 2022 | Aug 15, 2022 |
| EFFECT | Filing | Aug 12, 2022 | — |
| CORRESP | Letter to the SEC | Aug 10, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2022 | — |
| S-3 | Shelf registration | Aug 4, 2022 | — |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, Results of operations
|
Aug 4, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2022 | Jun 28, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Officer or director change
|
May 2, 2022 | May 2, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 14, 2022 | Apr 14, 2022 |
| S-8 | Employee stock plan registration | Mar 8, 2022 | — |
| 10-K | Annual report | Mar 8, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2021 | Nov 4, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 27, 2021 | Jul 21, 2021 |
| 424B3 | Prospectus | Jul 12, 2021 | — |
| EFFECT | Filing | Jul 9, 2021 | — |
| CORRESP | Letter to the SEC | Jul 6, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2021 | — |
| S-3 | Shelf registration | Jun 25, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Officer or director change
|
May 27, 2021 | May 27, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 12, 2021 | May 12, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2021 | — |
| DEF 14A | Proxy statement | Apr 21, 2021 | Jun 1, 2021 |
| S-8 | Employee stock plan registration | Mar 3, 2021 | — |
| 10-K | Annual report | Mar 3, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2021 | Mar 3, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2020 | Dec 22, 2020 |
| CT ORDER | Filing | Dec 21, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Nov 9, 2020 | Nov 9, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2020 | Aug 31, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 30, 2020 | Jun 24, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 30, 2020 | Jun 24, 2020 |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| 424B5 | Prospectus supplement | Jun 24, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2020 | Jun 5, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 5, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2020 | Apr 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 16, 2020 | Apr 16, 2020 |
| S-8 | Employee stock plan registration | Mar 3, 2020 | — |
| 10-K | Annual report | Mar 3, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2020 | Mar 3, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 10-Q | Quarterly report | Nov 13, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2019 | Nov 13, 2019 |
| CT ORDER | Filing | Sep 10, 2019 | — |
| 424B5 | Prospectus supplement | Aug 21, 2019 | — |
| EFFECT | Filing | Aug 19, 2019 | — |
| CORRESP | Letter to the SEC | Aug 14, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2019 | — |
| S-3 | Shelf registration | Aug 8, 2019 | — |
| S-8 | Employee stock plan registration | Aug 8, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DNTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1690585
- Former names
- Magenta Therapeutics, Inc. (until Sep 8, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.